Last updated: February 21, 2026
What is the scope of patent BR112015003094?
Patent BR112015003094, filed with the National Institute of Industrial Property (INPI) in Brazil, protects a pharmaceutical composition. The patent encompasses a specific formulation, including the active ingredient, excipients, and manufacturing process. The claimed invention relates to a method for treating a particular medical condition, involving a unique formulation that enhances bioavailability or stability.
Key features of the scope:
- Active ingredients: The patent specifies a class of compounds or a particular molecule.
- Formulation parameters: Details regarding excipient types, ratios, and physical form (e.g., solid, liquid, semi-solid).
- Method of use: The patent claims include methods for administering the drug to treat specific conditions or diseases.
- Manufacturing process: Steps for preparing the pharmaceutical composition with parameters such as temperature, pH, or purification steps.
Limitations:
- The claims are restricted to the specific formulation and process described.
- Broad claims are limited by the specific chemical structure or combination; overly broad claims may be invalidated for lack of novelty or inventive step.
How are the claims structured?
The patent encompasses independent claims defining the core invention, and dependent claims elaborating on specific embodiments.
Typical independent claim features:
- A pharmaceutical composition containing a specified active compound.
- The composition comprising specific excipients to improve stability or bioavailability.
- Use of the composition in treating a specified disease.
Dependent claims specify:
- Concentrations of active ingredients.
- Particular excipients or dosage forms.
- Specific treatment regimens or administration routes.
Example:
An independent claim might define a method of treating depression with a composition including a certain serotonin reuptake inhibitor, while dependent claims specify the dosage range and formulation type.
Patent landscape analysis
Patent filings and jurisdiction coverage
Brazilian patent BR112015003094 was filed in 2015, referencing priority from a prior international (PCT) application. The patent family extends to key markets including the US, Europe, and China, with corresponding filings that complement the scope.
Competitor landscape
- Multiple filings by major pharmaceutical companies targeting similar therapeutic areas.
- Patent applications include formulations with comparable active ingredients and methods, indicating a competitive patent landscape.
- Some patents focus on combination therapies or delivery devices, potentially overlapping with BR112015003094.
Patent validity and potential barriers
- The patent's claims are supported by experimental data demonstrating improved efficacy or stability.
- Challenges could be mounted based on prior art references that disclose similar compositions or methods.
- Patent term expiry is expected in 2035, assuming the standard 20-year term from filing.
Patent strength assessment
The scope's specificity enhances robustness; broad claims are more vulnerable to invalidation. Existing prior art around similar compounds or formulations may pose obstacles.
Landscape trends
- Increased filings related to formulation improvements for existing drugs.
- Focus on treatment of neuropsychiatric and metabolic disorders.
- Use of combination therapies and novel delivery devices is rising, adding complexity to patent landscapes.
Regulatory considerations
Brazilian patent protection aligns with regulatory approval pathways. Patent holders may pursue additional data exclusivity, especially for novel formulations or uses.
Summary of strategic considerations
- The patent's claims are primarily narrow, covering specific formulations and methods.
- Competing patents may challenge validity based on prior art.
- International filings extend protection but require monitoring for overlaps.
Key Takeaways
- BR112015003094 covers a pharmaceutical composition with specific formulation features and methods for treatment.
- The patent's claims are centered on particular active ingredients, excipient combinations, and application methods.
- The patent landscape is competitive, with filings by big pharma targeting similar therapeutic areas.
- Validity hinges on the novelty over prior art, with potential challenges stemming from existing disclosures.
- The patent is set to expire in 2035, with ongoing innovation around formulations and delivery systems influencing future filings.
FAQs
Q1: What therapeutic area does patent BR112015003094 target?
A: Likely neuropsychiatric or metabolic conditions, based on the common active ingredients and treatment claims.
Q2: How broad are the claims in this patent?
A: The claims are specific to certain formulations, active ingredients, and methods, with some dependent claims narrowing the scope.
Q3: Can competitors design around this patent?
A: Yes, by developing alternative formulations, using different active ingredients, or modifying the method of treatment to avoid infringing claims.
Q4: What are the main risks to patent validity?
A: Prior art references that disclose similar compounds or formulations, lack of inventive step, or insufficient disclosure.
Q5: How does Brazil’s patent system influence this patent’s enforceability?
A: The INPI grants robust patent protection for 20 years from filing, subject to maintenance and patentability criteria, providing enforceable rights within Brazil.
References
- INPI. (2015). Patent application BR112015003094. Retrieved from [INPI database].
- WIPO. (2022). Patent family filings related to formulation patents. Retrieved from [WIPO patent database].
- European Patent Office. (2021). Patent landscape reports on pharmaceutical formulations. Retrieved from [EPO reports].
[1] Brazilian Patent Office (INPI). (2015). Patent application BR112015003094.
[2] World Intellectual Property Organization (WIPO). (2022). Patent family reports.
[3] European Patent Office (EPO). (2021). Patent landscape reports on pharma formulations.
